一種針對貓過敏患者的疫苗正在研制中

一種針對貓過敏患者的疫苗正在研制中

Cat allergy got you in mew-sery? This news may change your life fur-ever.

貓過敏，你得了嗎?這個消息可能永久改變你的生活。

A team of scientists from the Swiss firm HypoPet AG has developed a vaccine to combat the feline-produced protein Fel d 1, to which 10% of humans are allergic, according to their press release.

瑞士HypoPet AG公司的一組科學家，已經開發(fā)出一種疫苗來對抗貓產生的蛋白質fel d 1，據他們的新聞稿顯示，10%的人對它過敏。

After analyzing data from four separate studies involving a total of 54 kitties, the antidote, called HypoCat, has already demonstrated its success.

在分析了四項涉及54只小貓的獨立研究的數據后，這種名為“低貓”的解藥已經證明了它的成功。

“Our HypoCat vaccine is able to produce high levels of antibodies in cats,” writes Gary Jennings, CEO of HypoPet AG, in the statement. “These antibodies can bind and neutralize the Fel d 1 allergen produced by the animals.”

HypoPet AG公司的首席執(zhí)行官加里·詹寧斯在聲明中寫道：“我們的低劑量貓流感疫苗，能夠在貓體內產生高水平的抗體。”“這些抗體可以結合并中和動物產生的Fel d1過敏源。”

Researchers say they are “pressing ahead with registration studies and discussions with European and US regulators” to bring the drug to market, which would certainly change lives.

研究人員說，他們正在“推進注冊研究，與歐洲和美國監(jiān)管機構的討論”，盡快將這種藥物推向市場，這肯定會改變人們的生活。

The vaccine would help those with cat allergies avoid typical reactions such as rashes, nasal congestion and irritated eyes, while also lowering their risk of exacerbating asthma or developing chronic respiratory issues.

這種疫苗可以幫助那些患有貓過敏的人避免典型的反應，如皮疹、鼻塞和眼睛發(fā)炎，同時也降低他們患哮喘或慢性呼吸道疾病的風險。